Kimberly Gentile

CIK 1704186 · SVP, Clinical Operations · last filed 2026-03-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.15M

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$6.10M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BHVN	SVP, Clinical Operations	101,513	$11.28	$1.15M	-$6.10M	26	2026-03-03
Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted	SVP, Clinical Operations	0	—	—	$0	1	2022-10-03

Recent Filings · Page 2 of 3

28 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2020-11-27	BHVN	Mixed	+2,049	-$153.3K	EDGAR
2020-10-09	BHVN	Mixed	—	-$1.58M	EDGAR
2020-06-18	BHVN	Mixed	—	-$25.8K	EDGAR
2020-06-17	BHVN	Mixed	—	-$1.55M	EDGAR
2020-06-10	BHVN	Mixed	—	-$38.7K	EDGAR
2020-01-10	BHVN	Exer (M)	+1,590	$49.8K	EDGAR
2019-12-20	BHVN	Mixed	+2,049	-$88.7K	EDGAR
2019-11-27	BHVN	Grant (A)	—	$0	EDGAR
2019-11-22	BHVN	Mixed	—	-$1.31M	EDGAR
2019-07-01	BHVN	Grant (A)	—	$0	EDGAR

Showing 11–20 of 28

Prev Page 2 of 3 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.